156 related articles for article (PubMed ID: 37273107)
41. MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis.
Leite KR; Tomiyama A; Reis ST; Sousa-Canavez JM; Sañudo A; Camara-Lopes LH; Srougi M
Urol Oncol; 2013 Aug; 31(6):796-801. PubMed ID: 21880514
[TBL] [Abstract][Full Text] [Related]
42. Integrated Analysis Reveals together miR-182, miR-200c and miR-221 Can Help in the Diagnosis of Prostate Cancer.
Gu Y; Lei D; Qin X; Chen P; Zou YM; Hu Y
PLoS One; 2015; 10(10):e0140862. PubMed ID: 26484677
[TBL] [Abstract][Full Text] [Related]
43. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
[TBL] [Abstract][Full Text] [Related]
44. A study of molecular signals deregulating mismatch repair genes in prostate cancer compared to benign prostatic hyperplasia.
Basu S; Majumder S; Bhowal A; Ghosh A; Naskar S; Nandy S; Mukherjee S; Sinha RK; Basu K; Karmakar D; Banerjee S; Sengupta S
PLoS One; 2015; 10(5):e0125560. PubMed ID: 25938433
[TBL] [Abstract][Full Text] [Related]
45. Molecular assays for the detection of microRNAs in prostate cancer.
Siva AC; Nelson LJ; Fleischer CL; Majlessi M; Becker MM; Vessella RL; Reynolds MA
Mol Cancer; 2009 Mar; 8():17. PubMed ID: 19267923
[TBL] [Abstract][Full Text] [Related]
46. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.
Su SF; Chang YW; Andreu-Vieyra C; Fang JY; Yang Z; Han B; Lee AS; Liang G
Oncogene; 2013 Sep; 32(39):4694-701. PubMed ID: 23085757
[TBL] [Abstract][Full Text] [Related]
47. Methylation-associated miR-193b silencing activates master drivers of aggressive prostate cancer.
Mazzu YZ; Yoshikawa Y; Nandakumar S; Chakraborty G; Armenia J; Jehane LE; Lee GM; Kantoff PW
Mol Oncol; 2019 Sep; 13(9):1944-1958. PubMed ID: 31225930
[TBL] [Abstract][Full Text] [Related]
48. MAPK and JAK/STAT pathways targeted by miR-23a and miR-23b in prostate cancer: computational and in vitro approaches.
Aghaee-Bakhtiari SH; Arefian E; Naderi M; Noorbakhsh F; Nodouzi V; Asgari M; Fard-Esfahani P; Mahdian R; Soleimani M
Tumour Biol; 2015 Jun; 36(6):4203-12. PubMed ID: 25604141
[TBL] [Abstract][Full Text] [Related]
49. Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients.
Slattery ML; Mullany LE; Sakoda LC; Wolff RK; Samowitz WS; Herrick JS
Apoptosis; 2018 Apr; 23(3-4):237-250. PubMed ID: 29516317
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cells.
Li X; Chen YT; Josson S; Mukhopadhyay NK; Kim J; Freeman MR; Huang WC
PLoS One; 2013; 8(8):e70987. PubMed ID: 23951060
[TBL] [Abstract][Full Text] [Related]
51. Prostate cancer small non-coding RNA transcriptome in Arabs.
Shan J; Al-Rumaihi K; Chouchane K; Al-Bozom I; Rabah D; Farhat K; Chouchane L
J Transl Med; 2017 Dec; 15(1):260. PubMed ID: 29268752
[TBL] [Abstract][Full Text] [Related]
52. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1.
Rajendiran S; Parwani AV; Hare RJ; Dasgupta S; Roby RK; Vishwanatha JK
Mol Cancer; 2014 Nov; 13():250. PubMed ID: 25406943
[TBL] [Abstract][Full Text] [Related]
54. Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.
Hirata H; Hinoda Y; Shahryari V; Deng G; Tanaka Y; Tabatabai ZL; Dahiya R
Br J Cancer; 2014 Mar; 110(6):1645-54. PubMed ID: 24504368
[TBL] [Abstract][Full Text] [Related]
55. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
Feng F; Wu J; Gao Z; Yu S; Cui Y
Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
[TBL] [Abstract][Full Text] [Related]
57. Large-scale integration of MicroRNA and gene expression data for identification of enriched microRNA-mRNA associations in biological systems.
Gunaratne PH; Creighton CJ; Watson M; Tennakoon JB
Methods Mol Biol; 2010; 667():297-315. PubMed ID: 20827542
[TBL] [Abstract][Full Text] [Related]
58. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
Khan MM; Serajuddin M; Bharadwaj M
Biomarkers; 2023 Mar; 28(2):227-237. PubMed ID: 36644827
[No Abstract] [Full Text] [Related]
59. Genetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancer.
Liu J; Huang J; He Y; Liu J; Liao B; Liao G
Mol Carcinog; 2014 Apr; 53(4):280-5. PubMed ID: 23065910
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA-27a-5p regulation by promoter methylation and MYC signaling in prostate carcinogenesis.
Barros-Silva D; Costa-Pinheiro P; Duarte H; Sousa EJ; Evangelista AF; Graça I; Carneiro I; Martins AT; Oliveira J; Carvalho AL; Marques MM; Henrique R; Jerónimo C
Cell Death Dis; 2018 Feb; 9(2):167. PubMed ID: 29415999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
